Latest AI and machine learning research in venous thrombosis for healthcare professionals.
PURPOSE OF REVIEW: Intraprocedural anticoagulation during percutaneous coronary intervention (PCI) remains particularly challenging in high-risk and underrepresented populations, where the balance between thrombotic and bleeding risk is complex and often unpredictable. This review summarizes contemporary evidence and remaining knowledge gaps regarding anticoagulant selection, dosing, and monitorin...
Background In patients with unprovoked venous thromboembolism (VTE), indefinite anticoagulation is recommended to prevent recurrence but may expose some patients to unnecessary long-term bleeding risk. Current clinical scores and biomarkers have limited discriminative performance, do not capture the time-dependent nature of VTE, and do not incorporate patients' perspectives or support shared decis...
Internal medicine involves high-stakes, time-sensitive decisions (such as triaging acute illnesses, escalating care, providing thromboprophylaxis, pla...
Current pharmacometrics (PMX) model development is a manual process with iterative model building, fitting, and evaluation, which can be resource-inte...
INTRODUCTION: Transcatheter aortic valve replacement (TAVR) has transformed the management of severe aortic stenosis across all surgical risk strata. ...
Recurrent ischemic stroke remains a major global health challenge, accounting for substantial disability and mortality despite advances in acute manag...
BACKGROUND: The relationship between NEK7-NLRP3 inflammasome activation and elevated platelet activity in the progression of heart failure (HF) is not...
The design of proteins that bind to small molecules has been challenging because it requires simultaneous optimization of the protein sequence, protei...
Left ventricular thrombus (LVT) in ischemic heart failure carries embolic risk; tools to anticipate persistence are limited. We studied 190 consecutiv...
Deep vein thrombosis (DVT) is the formation of thrombi in the deep venous system, most often in the lower extremities. Although usually not life-threa...
Deep vein thrombosis (DVT) remains difficult to distinguish because of its often silent presentation and the limited specificity of current diagnostic...
AIM: Machine learning (ML) applications in pharmacovigilance remain limited and underexplored. Using data from the French National pharmacovigilance d...
BACKGROUND: Deep vein thrombosis (DVT) following total knee arthroplasty (TKA) remains a major postoperative complication. Conventional risk assessmen...
Balancing thromboembolic prevention against bleeding risk remains a key challenge during oral anticoagulant (OAC) therapy. CHAâ‚‚DSâ‚‚-VASc cannot predict...
Pharmacogenomics (PGx) is transforming how we treat cardiovascular disease (CVD) by enabling us to select and dose drugs based on our genetic profiles...
INTRODUCTION: Chronic subdural hematoma (cSDH) predominantly affects older adults, often those with prior head trauma, anticoagulation therapy, or chr...
OBJECTIVE: The purpose of this study was to create a risk score for loss of aorto-bifemoral artery bypass (ABF) patency utilizing preoperative, periop...
BACKGROUND: Older patients with patellar fractures may be at increased risk of postoperative deep vein thrombosis (DVT) because of trauma, perioperati...
Previously, we reported a dual combination based on 4-hydroxycoumarin and dodecanedioic acid that could synergistically bind to human serum albumin (H...
BACKGROUND: Warfarin dosing in cancer patients is challenging due to altered pathophysiology and variable responses. While machine learning offers pre...